David Sparling

David Sparling is an accomplished executive with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Site Head Australia at BioNTech SE since April 2024, David previously held key leadership roles including Chief Executive Officer at IDT Australia Limited and Freedom Eye Limited, along with positions in corporate development and legal affairs at Genetic Technologies Limited and Agenix Limited. David's early career included a veterinary practice at CoastVet. With advanced education including a Certificate in Executive Leadership from Saïd Business School at the University of Oxford and a Bachelor's degree in Law from Bond University, David combines legal expertise with business acumen to drive organizational success.